Form 4: Hims & Hers Health CFO Oluyemi Okupe Sells Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
Oluyemi Okupe, CFO of Hims & Hers Health, Inc., sold 11,546 shares of Class A Common Stock at an average price of $22.2146 on June 25, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On June 25, 2024, Oluyemi Okupe, the Chief Financial Officer of Hims & Hers Health, Inc., sold 11,546 shares of Class A Common Stock.
- The sale was executed at an average weighted price of $22.2146 per share, with individual prices ranging from $22.16 to $22.285.
- The transaction was conducted under a Rule 10b5-1 trading plan adopted by Okupe on May 10, 2023.
- Following the transaction, Okupe directly owns 177,449 shares of Hims & Hers Health, Inc.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating a routine stock sale by an insider under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment.
Industry Context
Insider sales are a common occurrence, and the use of a 10b5-1 trading plan suggests the sale was pre-planned and not based on any specific non-public information.
Stakeholder Impact
- The sale of shares by a high-ranking officer could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| May 10, 2023 | Date the Reporting Person adopted a Rule 10b5-1 trading plan |
| June 25, 2024 | Date of the stock sale transaction |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.